Encouragingly, protection from amebiasis in humans has been associated with mucosal IgA and IFNγ production from PBMCs (5, 6); in addition, IL-17A production from splenocytes was associated with protection in a mouse challenge model (7). The gene discussed is IFNG; the disease is amebiasis.